HoloMD, a Rockville, Maryland-based AI-powered remote therapeutic monitoring (RTM) platform for psychiatry, has raised $1.6 million in the first close of its Seed round.
Investors
The round includes participation from undisclosed investors, with additional funds expected to close soon.
HoloMD Use of Funds
The company will use the funds to accelerate the development and expansion of Dr. Holo™, its AI-powered mental health companion, and to support HoloMD’s growth into additional psychiatric practices and markets.
About HoloMD
HoloMD is an AI-powered remote therapeutic monitoring (RTM) platform built by psychiatrists for psychiatrists and psychiatric mental health nurse practitioners (PMHNPs). Its flagship product, Dr. Holo™, an AI-powered mental health companion, provides daily patient engagement, evidence-based interventions, and clinical insights to support care between visits. HoloMD combines automation with human oversight to enhance psychiatric outcomes and reduce clinician burnout. Founded in July 2024, the company is fully HIPAA- and HITECH-compliant.
Funding Details
Company: HoloMD, Inc.
Raised: $1.6M
Round: Seed
Funding Date: November 2025
Lead Investor: Not disclosed
Additional Investors: Not disclosed
Company Website: https://holomd.ai/
Software Category: HealthTech / AI Mental Health Platform
Source: https://www.businesswire.com/news/home/20251104098142/en/